期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
^(117m)Sn在肿瘤治疗中的应用 被引量:3
1
作者 何佳恒 李首建 《化学研究与应用》 CAS CSCD 北大核心 2007年第6期583-588,共6页
117mSn作为一个核性质比较优良的放射性核素,在近十年内成为医学领域科研人员的关注热点。本文综述了117mSn的性质、制备以及其标记化合物的研究进展。
关键词 ^^117msn ^^117msn-DTPA
下载PDF
^(117m)Sn-TTHMP的制备及生物性质研究 被引量:3
2
作者 何佳恒 王关全 +2 位作者 蒋述斌 刘国平 李首建 《化学研究与应用》 CAS CSCD 北大核心 2006年第10期1162-1166,共5页
合成了具有亲骨性的氨基膦酸配体-TTHMP(三乙基四胺六甲撑膦酸),制备了117mSn(Ⅳ)-TTHMP,对配合物的稳定性、亲脂性作了研究,考察了它在大白兔体内显像及小鼠体内的分布。将其生物性质与已有文献报道的117mSn(Ⅳ)-HEDTMP作了比较。结果... 合成了具有亲骨性的氨基膦酸配体-TTHMP(三乙基四胺六甲撑膦酸),制备了117mSn(Ⅳ)-TTHMP,对配合物的稳定性、亲脂性作了研究,考察了它在大白兔体内显像及小鼠体内的分布。将其生物性质与已有文献报道的117mSn(Ⅳ)-HEDTMP作了比较。结果表明117mSn(Ⅳ)-TTHMP的制备简单,稳定性好,亲水,117mSn(Ⅳ)-TTHMP的靶向摄取率高于前两者,是一种极具潜力的新型放射性药物。 展开更多
关键词 ^^117msnTTHMP 骨肿瘤
下载PDF
Adsorption of ^(117m)Sn(IV)-EDTMP on hydroxyapatite and collagen
3
作者 YANGYu-Qing LUOShun-Zhong 《Nuclear Science and Techniques》 SCIE CAS CSCD 2002年第2期98-104,共7页
Some organic phosphines labeled with ^117mSn(IV) have been proved promising for imaging and pain palliation of bone tumor.In this paper,a preliminary investigation on the adsorption characteristics of EDTMP(ethelenedi... Some organic phosphines labeled with ^117mSn(IV) have been proved promising for imaging and pain palliation of bone tumor.In this paper,a preliminary investigation on the adsorption characteristics of EDTMP(ethelenediaminetetramethylene phosphoric acid)labeled with ^117Sn(IV) on HA( hydroxyapatitie)and collagen,and an investigation on the adsorption mechanism of ^117mSn(IV)-EDTMP on HA was presented. 展开更多
关键词 蛋白 羟基磷灰石 ^^117msn(IV)示踪 吸附
下载PDF
Preparation and characteristics of ^(117m)Sn-HEDTMP
4
作者 HEJia-Heng LUOShun-Zhong 《Nuclear Science and Techniques》 SCIE CAS CSCD 2002年第2期105-109,共5页
Tin-117m(t1/2 14d; γ 159keV, 86%) is an ideal tracer for studyingbiological behavior of tin compounds as well as for developing clinically-useful radio-pharmaceuticals. It had been reported that Sn-117m[4+] DTPA has ... Tin-117m(t1/2 14d; γ 159keV, 86%) is an ideal tracer for studyingbiological behavior of tin compounds as well as for developing clinically-useful radio-pharmaceuticals. It had been reported that Sn-117m[4+] DTPA has unexpectedlyhigh bone uptake and bone-to-blood ratio, and is potentially useful as an agent forskeletal scintigraphy and radiotherapy of bone tumors. In this work, HEDTMP [N-(2-hydroxyethyl) ethlenediamine-1,1,2-tri (methylene phosphonic acid)] was synthesized.Let it form complex with 117mSn. The formation conditions, stability and distributioncoefficient between oil and water of the complex were investigated. 展开更多
关键词 骨瘤 ^^117msn-HEDTMP 制备
下载PDF
In-vivo behavior of tin-radiopharmaceuticals
5
作者 HE Jia-Heng, LUO Shun-Zhong, WANG Guan-Quan, YANG Yu-Qing, PU Man-Fei, LIU Guo-Ping (Institute of Nuclear Physics and Chemistry, the Chinese Academy of Engineering Physics, Mianyang 621900) 《Nuclear Science and Techniques》 SCIE CAS CSCD 2003年第2期127-130,共4页
Tin is an essential ingredient of most technetium-99m radiopharmaceuticals but its in-vivo distribution and long-term fate are not well understood. This work describes distribution in mice of several tin-117m labeled ... Tin is an essential ingredient of most technetium-99m radiopharmaceuticals but its in-vivo distribution and long-term fate are not well understood. This work describes distribution in mice of several tin-117m labeled compounds. The results indicate that stannic-HEDTMP appears to be the best overall bone localizing agent with very low blood, muscle, kidney, or liver uptake, and its binding to bone is higher than that of tin-117m-DTPA, which make it potentially useful as an agent for skeletal scintigraphy and radiotherapy of bone tumors. 展开更多
关键词 放射性药品 骨肿瘤 闪烁扫描法 放射线疗法
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部